SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.84+3.8%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Skeeter Bug who wrote (29987)1/9/2000 12:10:00 AM
From: Henry Niman  Read Replies (1) of 32384
 
Speaking of miracles, several years ago a poster on the AOL LGND board indicated that he had bought some LGND because his mother or grandmother had CTCL and treatment with Targretin produced results similar to those described in the testimonials.

About the same time there were two newspaper reports on head and neck patients treated with a new drug by LGND (tumors were huge, had not responded to prior treatments, and melted away when treated with Ligand's drug). I had always assume that it was Targretin (one patient was at MD Anderson and the other was at the Lombardi Cancer Center). There wasn't much follow-up and a small head & neck study using Targretin did not produce objective tumor responses.

Now that Targretin has been approved, it might be worth dusting off those old reports and revisit use of Targretin for Head & Neck. A few more pieces of anecdotal evidence may go a long way toward off label use of a "newly approved cancer pill".
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext